NASDAQ

enGene Therapeutics Inc. - Warrants (ENGNW)

♥ 575 Thanks from members

Community market perspectives and discussion for enGene Therapeutics Inc. - Warrants (NASDAQ: ENGNW).

No chart available for this instrument.

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Dr. Ronen TcheletFounder: Miriam SegreLeadership: Jason Leverone (CEO)Leadership: Chief Scientific OfficerHolder: EcoR1 CapitalHolder: Pontifax Venture CapitalEG-70 for Bladder CancerGene Delivery Platforms#ENGNW#enGene Therapeutics Warrants#NASDAQ ENGNW#biotech warrants#gene therapy stock